International Journal of Biomaterials

International Journal of Biomaterials / 2020 / Article

Research Article | Open Access

Volume 2020 |Article ID 3637098 |

Jeimmy González-Masís, Jorge M. Cubero-Sesin, Yendry Regina Corrales-Ureña, Sara González-Camacho, Nohelia Mora-Ugalde, José Roberto Vega-Baudrit, Klaus Rischka, Virendra Verma, Rodolfo J. Gonzalez-Paz, "Nonirritant and Cytocompatible Tinospora cordifolia Nanoparticles for Topical Antioxidant Treatments", International Journal of Biomaterials, vol. 2020, Article ID 3637098, 9 pages, 2020.

Nonirritant and Cytocompatible Tinospora cordifolia Nanoparticles for Topical Antioxidant Treatments

Academic Editor: Wen-Cheng Chen
Received08 Apr 2020
Revised21 Jun 2020
Accepted09 Jul 2020
Published21 Aug 2020


Tinospora cordifolia extract contains antioxidants such as polyphenols, and thus, it has been used as a natural phytochemical antioxidant therapeutic agent. Many of these compounds are insoluble or only partially soluble in water. In this study, we produced a novel aqueous nanoparticle formulation, with an average particle size of 182.9 ± 3.8 nm, to improve the dispersion of the bioactive compounds in water and to increment its bioavailability. The nanoparticles are composed of polyphenols, alkaloids, and glycosides. We studied the effect of this nanoparticle formulation on mouse 3T3 fibroblast cell viability and New Zealand rabbit dermal irritability tests. Concentrations of 2.5, 25, and 250 µg/mL resulted in similar cell viability to cells in culture media. An intermediate concentration of 12.45 mg/ml was used for the acute dermal irritability test. There were no severe alterations that compromised animal health. These results represent a precedent for application of such nanoparticles derived from plant stems, such as Tinospora cordifolia, in biomedicine and in antiaging cosmetic treatments.

1. Introduction

Tinospora cordifolia, also known as Guduchi, is a deciduous climbing shrub, found in India, especially in tropical areas, being famous for its numerous properties and uses in the ancient Ayurveda and Tibetan medicinal system [1]. Tinospora cordifolia is found ascending to an altitude of 1000 feet in Southeast Asian countries such as Indonesia, the Philippines, Thailand, Myanmar, China, and Sri Lanka [2]. It is used to prepare tonics, vitalizers, antiallergics, and treatments for diabetes mellitus, among others [3, 4]. The beneficial properties of this plant are associated with a large number of chemical components, such as alkaloids, diterpenoid lactones, glycosides, steroids, sesquiterpenoids, phenolic compounds, and aliphatic compounds that present immunomodulatory activities [5]. These compounds exist in plant stem, leaves, roots, and fruits [4]. Several studies have reported that Tinospora cordifolia ethanolic extract (TEC) exhibits higher antioxidant activity, using in vitro antioxidant activity screening models such as nitric oxide and superoxide radical scavenging activity, inhibition of lipid peroxidation, and reduction of ferric ions [6]. This antioxidant properties are attributed to the strong free radical scavenging properties against superoxide anion (O2−) and hydroxyl radicals (OH), through a series of coupled reactions with the help of enzymes [7, 8]. In regards to toxicity and side effects, the Ayurvedic literature reports that Tinospora can cause constipation, if it is taken regularly at high doses. However, it has been reported that no side effects or adverse reactions have been observed when the stem extract of Tinospora was administered in rabbits up to an oral dose as high as 1.6 g/kg and to rats up to a dose of 1 g/kg of total plant extract. Little is known about the toxicology of this product in humans [9]. The presence of compounds such as 2,4-bis(1,1-dimethyl-ethyl)-phenol and palmitic acid could provide the antioxidant properties [10]. Many of these compounds are partially soluble in water, and this limits its use in aqueous formulations. The usual preparation protocol is to cut part of the plant into small pieces, let to dry (usually in the shade), and grind these pieces to produce a powder, which can be dispersed in water-ethanol or methanol mixtures [1, 3, 9]. To improve the solubility in water and increase the bioavailability of the bioactive compounds, we will produce a nanosuspension of TEC in water applying sonication and filtration to decrease the aggregate sizes of insoluble compounds. Characterization techniques such as using Fourier-transform infrared spectroscopy (FTIR), gas chromatography-mass spectrometry (GC-MS), and 13C- and 1H-NMR (nuclear resonance spectroscopy) were used. The nanoparticle suspensions will be characterized using dynamic light scattering (DLS) and atomic force microscopy (AFM) to determine their particle size and morphology. The effect of the Tinospora cordifolia nanoparticle suspension on 3T3 fibroblast viability and animal dermal irritability was also evaluated.

2. Experimental

2.1. Production of Nanoparticle Aqueous Formulation

Dried Tinospora cordifolia stems from Varanasi (latitude: 25°19′3.52″N and longitude: 82°58′26.09), India, were pulverized using an industrial blender and mixed with 250 mL of ethanol. The alcoholic solution, with a concentration of 104.7 mg/mL, was filtered and placed in an oven at 45°C for 16 h to obtain a dry extract. A 13.2 mg/mL aqueous suspension was prepared in ultrapurified water and sonicated to obtain the nanoparticulate solution. The conditions of the ultrasonic treatment were 4 W and 40% amplitude for 5 min, using a probe of 6 mm diameter. The solution was filtered with a sterile filter of 0.2 µm (Sartorius, Germany) and diluted to 2.5 μg/mL, 25 μg/mL, and 250 μg/mL concentrations using ultrapure water.

2.2. Characterization of the Tinospora cordifolia Extract and Nanoparticle Suspension
2.2.1. Fourier-Transform Infrared Spectroscopy (FTIR)

A Nicolet 6700 spectrophotometer was used, encompassing 4000 to 400 cm−1 wavenumber with a standard resolution of 0.09 cm−1 and a scanning speed of 32 spectrums/s.

2.2.2. Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-ToF MS)

Spectra were recorded on a Bruker Autoflex Speed (Bruker Daltonics, Bremen, Germany) mass spectrometer. The applied matrix was 2,5-dihydroxybenzoic acid (DHB, Sigma Aldrich, Germany) in methanol. The sample was dissolved in methanol. The matrix and sample were mixed in the ratio 10 : 1 (matrix : sample) and applied on a stainless steel target plate. The mixture was dried in the open air (dried droplet). A calibration was applied by using PEG 400. The spectrum was recorded in the positive reflection mode by the accumulation of 5 × 1000 scans.

2.2.3. Nuclear Magnetic Resonance Spectroscopy (NMR)

NMR spectra were recorded in CDCl3 as solvent, with a Bruker Advance DRX-600 spectrometer equipped with a Prodigy BBIO cryoprobe (1H at 600.22 MHz; 13C at 150.94 MHz). 1H shifts were calibrated by using the chemical shifts of the CDCl3 solvent signal (δ H = 7.26 ppm, 300K) as an internal standard [11]. 13C chemical shifts were calibrated using the IUPAC recommendations applying the conversion factor of 0.25144953 for the calculation of the absolute frequency of 13C (δ = 0.0 ppm) [12].

2.2.4. Total Polyphenol Content

Solutions with a concentration of 100, 50, 10, 5, and 1 µg/mL were prepared for the determination of the calibration curve. 0.75 mL of distilled water, 0.5 mL of the solutions, and 0.625 mL of the Folin reagent (1N) were placed in a volumetric flask of 5 mL. Then, the flask was filled with a solution of Na2CO3·10H2O (20% m/v). The mixtures were incubated for 40 min at room temperature in the dark. After the reaction period, the absorbance of the solutions was measured at a wavelength of 725 nm in a Shimadzu UV-Vis spectrophotometer (model UV-1800, Shimadzu Corporation, Kyoto, Japan).

2.2.5. Dynamic Light Scattering (DLS)

The average nanoparticle hydrodynamic diameter was measured using a Malvern Zetasizer instrument at 25°C.

2.2.6. Atomic Force Microscopy (AFM)

The 20 μL nanoparticle solution was placed on a freshly cleaved mica substrate and dried at room environmental conditions overnight. The sample topography was analyzed in air using an atomic force microscope (Asylum Research, Santa Barbara, CA), operated in the tapping mode. Silicon probes (model Tap150Al-G), backside with a resonance frequency of 150 kHz and a force constant of 5 N/m, were used.

2.2.7. Cell Culture

Mouse 3T3 fibroblast cell line (ATCC, USA) was incubated (Binder, Germany) and cultured in standard conditions (37°C, 5% CO2) in Dulbecco’s modified Eagle’s medium (DMEM, Gibco®). The medium was supplemented with 10% v/v fetal bovine serum (FBS) (Sigma-Aldrich) and changed every other day. The cells were subcultured using routine trypsin/EDTA (Merck) procedures.

2.2.8. Viability Assay

Exponentially growing 3T3 cells were seeded in a 96-well plate at a density of 700 cells/100 µL/well and left in the incubator growing for 24 h. Afterwards, 50 µl of the Tinospora cordifolia nanoparticle suspensions of 2.5, 25, and 250 µg/mL, containing resazurin salts (Sigma-Aldrich), was added to the culture with or without cells. Fluorescence readings were carried out using a microplate reader (Synergy H1 Hybrid, Biotek) with a gain of 70 at 0, 24, 48, and 72 h, and excitation and emission wavelengths of 540 and 590 nm, respectively. The fluorescence blank was subtracted from the average of the data (supernatant with the culture medium in the absence of the cells), and the percentage of viability was calculated using the following equation:

2.2.9. Acute Dermal Irritability Test

The test evaluated the irritability of the aqueous solution of Tinospora cordifolia nanoparticle suspension at a concentration of 12.45 mg/mL and pH of 7, on the healthy skin of a New Zealand rabbit.(a)Administration of the substance to be tested: at least 24 h before the test, the hair of the animals was carefully cut on both sides of the back, in an approximate area of 6 cm2. Only animals whose skin was intact were used. A single dose of 0.5 mL of the undiluted test substance was applied with a 4-hour exposure, after which the residual material was removed using distilled water, so as not to disturb the integrity of the epidermis.(b)Observation: inspections of the skin (erythema and edema) of the live animals were conducted at 24 h, 48 h, and 72 h after the administration of the test substance. Daily observation of the animals was conducted for 14 days after the application to determine the health status and subsequent responses or recovery. Weekends were omitted once it was demonstrated that after 72 hours of application, any signs of irritation or corrosion had disappeared.(c)Irritation evaluation method: the records of dermal irritation were evaluated in conjunction with the nature and reversibility of the observed response. The severity scores were assigned through the use of the Primary Skin Irritation Scale. The individual scores did not constitute an absolute norm for the irritating properties of a material. They were considered as reference values and were supported by a complete description and evaluation of the observations.(d)Classification of the substance to be tested: at the end of the observation period, the substance was classified according to the parameters given by the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) and the Organization for Economic Cooperation and Development (OECD), as shown in Tables 1 and 2. The parameters to evaluate the animal health and the scale are shown in Tables 3 and 4, and the scale for evaluation of erythema and edema reactions is shown in Table 5.

Corrosive (category 1)Corrosive potential subclassificationCorrosive in 1 or more animals

CorrosiveCorrosive subcategory 1A≤3 minutes≤1 hour
Corrosive subcategory 1B≤3 minutes to ≤1 hour≤14 days
Corrosive subcategory 1C> 1 hour to ≤4 hours≤14 days


Irritative (Category 2)(1) Average of ≥2.3 ≤ 4.0 for erythema/eschar or for edema in at least 2 of the 3 animals tested at 24 hours, 48 hours, and 72 hours after removing the patch, or if the reactions are delayed, for classifications in 3 consecutive days after the appearance of skin reactions, or
(2) inflammation that persists at the end of the observation period, normally 14 days and in at least 2 animals, particularly taking into account alopecia (defined area) hyperkeratosis, hyperplasia, and flaking, or
(3) in some cases when there is a pronounced response variability between the animals, with well-defined positive effects related to the exposure chemical in an animal but less than the previous criteria

Medium irritant (Category 3)Average of ≥1.5 < 2.3 for erythema/eschar or for edema in at least 2 of the 3 animals tested at 24 hours, 48 hours, and 72 hours or, if the reactions are delayed, for ratings on 3 consecutive days after the onset of skin reactions (when they are not included in the previous category of irritation)

Not irritatingWhen the criteria of Categories 1–3 are not met


Hair appearanceTexture, color, fall
Skin appearanceRedness, dryness, exudation
Eyes and mucous membranesRedness, dryness, abnormal secretion
AtaxiaLoss of balance, erratic walk
ParalysisLoss of response in any limb
Reaction to stimuliResponse to touch or noise
Peripheral vasoconstrictionPallor
Peripheral vasodilationRedness
PiloerectionStiff hair
SalivationExcess of buccal secretion
Motor activityIncrease or decrease in normal activity, reflect or not
Tremors and convulsionsSpontaneous abnormal muscle contraction, contraction or uncontrolled muscular stretching
BreathingIncrease or decrease in respiratory rate
DehydrationRobin’s test: pinching the skin, without returning to its normal position
DiarrheaSoft stools or watery stool
LoseWeight lose


0There is no alteration
1Mild alteration that does not affect the other parameters
2Moderate alteration that does not affect the general behavior of the animal
3Severe alteration that affects the general behavior of the animal

Erythema formationValueEdema formationValue

No presence of erythema0No edema formation0
Very slight erythema (almost imperceptible)1Very slight edema (almost imperceptible)1
Well-defined erythema2Light edema (well-defined area with significant elevation)2
Moderate-to-severe erythema3Moderate edema (elevation of approximately 1 mm)3
Severe erythema (red beet) with formation of scabs (deep lesions)4Severe edema (elevation greater than 1 mm and extending beyond the exposure area)4
Maximum possible4Maximum possible4

3. Results and Discussion

The chemical structure of the natural extract (TEC) and the nanoparticle suspensions (TEC-NPs) was analyzed using FTIR, as shown in Figure 1(a). The TEC spectrum shows a peak at 3380 cm−1 and 1080 cm−1 from the hydroxyl group, corresponding to free alcohols and/or water. The peak at 3395 cm−1 could be associated with phenolic compounds [9, 13]. The presence of hydroxyl groups could be associated with compounds such as polyphenols, fatty acids, and monosaccharides [13, 14]. The peak at 1730 cm−1 is associated with the stretching vibration of the C=O steroids [9, 14, 15]. The peak at 1630 cm−1 corresponds to the C=C bond of olefin. Peaks at 1180 cm−1 and 950 cm−1, both present in the nanoparticles and the extract, could be associated with the stretching vibrations of the C=O and C-O-C groups, respectively [15]. Also, near 720 cm−1, a strong band appears, typical of the C-H groups [1, 16]. Comparison of the bands of the extract and the nanoparticles reveals peak shifts at higher wavenumbers, as well as an increase in the intensity of the absorption bands. This result suggests that some compounds could be less soluble in water than in ethanol, and their aggregates were removed during filtration. Also, the difference in chemical environment that influences the hydrogen bond formation and electrostatic interactions produce shifts on the absorption bands [17].

Figure 1(b) shows the peaks at m/z = 393.122 and m/z = 419.207, indicated by red dots, which are associated with compounds contained in the extract such as secondary metabolites and polyphenol oligomers [1820]. The compound at m/z = 419.207 corresponds to sodium adduct of tinocordiside, a tricyclic sesquiterpenoid glycoside [21]. A 2D model of the structure is shown in Figure 2.

Tinocordiside is a glycoside well known for its traditional uses in treatment of neurological disorders such as ALS, Parkinson’s disease, dementia, motor and cognitive deficits, and neuron loss in the spine and hypothalamus [23]. Immunomodulatory activity is also attributed to this compound [24] and for thrombolytic drugs [25]. The blue dots correspond to the DHB signal at m/z = 136.994, 154.004, 155.012, 177.004, 273.030, 300.150, and 361.976. The yellow dot at m/z = 279.086 corresponds to triphenylphoshinoxide + H+ that is correlated to contamination from the packaging container where the extract was stored.

The 13C-NMR spectral data in Figure 3(a) show C aromatic atoms at 121.3, 124.3, 127.8, 129.5, 130.16, 131.67, 133.8, 136.7, and 136.8 ppm, which correspond to C-H shifts from aromatic rings and are the fingerprint of alkaloids such as N-formylannonaine [26]. The C polyphenol fingerprint is 140.1, 142, and 145 ppm [27].

The 1H-NMR spectral data in Figure 3(b) show protons at 1.97 ppm assigned to CH2 groups, polysaccharides, or aromatic OH groups from polyphenols at 4.91 ppm, and the alkaloid fingerprint between 8 and 9 ppm [28]. Carbon 13C-NMR and 1H-NMR results confirm that preferential presence of polyphenols. The phenols in the extract were quantified using the Folin–Ciocalteu test. The results are shown in Table 6. The Folin–Ciocalteu reagent is sensitive to the reduction of hydroxyl groups of reducing sugars, and the values should be only taken as an approximation.

SampleConcentration (mg/mL)
MeanStandard deviation

Alcoholic extract0.940.02

The nanoparticle formation was confirmed using AFM. Figure 4(a) shows aggregates contained in the filtered ethanolic TEC extract with a height above 100 nm. The profiles of the aggregates show particles with heights between 60 and 150 nm and widths between 500 nm and 2 µm (Figure 4(c)). These aggregates could be correlated to the partially soluble and insoluble compounds previously described. Figure 4(b) shows nanoparticles with heights of 20–30 nm and an average of 560 ± 130 nm diameter, confirming the effectiveness of sonication and filtration processes in order to decrease the aggregate size and to form micellar-like structures, Figure 4(d). However, according to the DLS size distribution analysis, the sample is polydisperse (Figure 4(e)). Figure 4(f) shows aggregates of particles that tend to form on the mica surface, and these results suggest that aggregates could form in the solution and an extra cosurfactant could be added to stabilize the nanosuspension.

3.1. Nanoparticle Cytotoxicity and Irritability Tests

Significance difference in viability between the samples and the control was determined by an analysis of variance (ANOVA) test, followed by a Tukey post hoc test. No significant differences at between the control of viability (100% growth) and the TEC-NP solutions were found. All aqueous solutions of nanoparticles are not cytotoxic to the 3T3 cell line used, achieving an increase higher than the control (100%), as shown in Figure 5. The maximum value is obtained from the aqueous solution of nanoparticles with a concentration of 2.5 μg/mL, after 22 hours, whose viability is slightly higher than 140%.

As observed in the summary of Tables 7 and 8, there were no severe alterations that compromised animal health and welfare. There was also no obvious irritation of the test substance in contact with the skin. Therefore, the TEC-NP in the concentration 12.45 mg/mL is classified as nonirritating, since no evident irritation was observed during the entire period of the test. These results are consistent with the research of other authors, without obtaining adverse results [4, 29].

ErythemaDay 1Day 2Day 3Day 4Day 5Day 6Day 7

Hair appearance000000000000000000000
Skin appearance000000000000000000000
Eyes and mucous membranes000000000000000000000
Reaction to stimuli000000000000000000000
Peripheral vasoconstriction000000000000000000000
Peripheral vasodilation000000000000000000000
Motor activity000000000000000000000
Tremors and convulsions000000000000000000000

EdemaDay 8Day 9Day 10Day 11Day 12Day 13Day 14

Hair appearance000000000000000000000
Skin appearance000000000000000000000
Eyes and mucous membranes000000000000000000000
Reaction to stimuli000000000000000000000
Peripheral vasoconstriction000000000000000000000
Peripheral vasodilation000000000000000000000
Motor activity000000000000000000000
Tremors and convulsions000000000000000000000

4. Conclusions

Stable Tinospora cordifolia stem derivate nanoparticles, with a hydrodynamic diameter of 182.9 ± 3.8 nm, were obtained in water by sonication. Polyphenols, alkaloids, and tinocordiside compose the nanoparticles. The nanoparticle cellular viability tests showed that they do not decrease the 3T3 fibroblast viability at a concentration range of 2.5–250 μg/mL and that are cytocompatible. In addition, its effect in dermal irritability showed no skin irritation of the New Zealand rabbit at 12.45 mg/mL. In vivo tests could confirm the viability in humans and a potential application in biomedicine, antiageing formulations, or others.

Data Availability

The results used to support the findings of this study are available from the corresponding author upon request (

Conflicts of Interest

The authors declare that they have no conflicts of interest.


  1. R. Mishra and G. Kaur, “Tinospora cordifolia induces differentiation and senescence pathways in neuroblastoma cells,” Molecular Neurobiology, vol. 52, no. 1, 2014. View at: Publisher Site | Google Scholar
  2. U. Spandana, S. Liakhat, T. Nirmala, M. Santhi, and S. Sipai, “A review on tinospora cordifolia,” International Journal of Current Pharmaceutical Review and Research, vol. 4, no. 2, pp. 61–68, 2013. View at: Google Scholar
  3. G. Abiramasundari and M. Sreepriya, “Pro-stimulatory effects of tinospora cordifolia (menispermaceae) on SAOS-2 osteoblast cells implications on bona remodeling and therapy of osteoporosis,” Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 5, no. 3, pp. 354–363, 2014. View at: Google Scholar
  4. M. Imtiyaj, S. G. P. Harsha, and G. Ravishankar, “Pigment identification, antioxidant activity, and nutrient composition of Tinospora cordifolia (willd.) Miers ex Hook. f & Thoms fruit,” International Journal of Food Sciences and Nutrition, vol. 62, no. 3, pp. 239–249, 2011. View at: Google Scholar
  5. I. Aranha, F. Clemente, and Y. Venkatesh, “Immunostimulatory properties of the major protein from the stem of the ayurvedic medicinal herb, guduchi (Tinispora cordifolia),” Journal of Ethonopharmacology, vol. 139, pp. 366–372, 2011. View at: Google Scholar
  6. S. Jain, B. Sherlekar, and R. Barik, “Evaluation of antioxidant potntial of Tinospora cordifolia and tinospora sinensis,” International Journal of Pharmaceutical Sciences and Research, vol. 1, no. 11, pp. 122–128, 2010. View at: Google Scholar
  7. T. Khan, A. Ipshita, R. Mazumdar, A. Abdullah, G. Islam, and M. Rahman, “Bioactive polyphenol profiling and in-vitro antioxidant activity of Tinospora cordifolia Miers ex Hook F and Thoms: a potential ingredient for functional food development,” Bangladesh Journal of Scientific and Industrial Research, vol. 55, no. 1, pp. 23–34, 2020. View at: Publisher Site | Google Scholar
  8. S. Saha and S. Ghosh, “Tinospora cordifolia: one plant, many roles,” Ancient Science of Life, vol. 31, no. 4, pp. 151–159, 2012. View at: Google Scholar
  9. M. Pandey, S. Chikara, M. S. R. Vyas, and G. B. P. Thakur, “Tinospora cordifolia: a climbing shrub in health care management,” International Journal of Pharma and Bio Sciences, vol. 3, no. 4, pp. 612–628, 2012. View at: Google Scholar
  10. P. Ruthiran, L. Ravi, and I. Selvaraj, “Phytochemical screening, FT-IR and gas chromatography mass spectrometry analysis of Tinospora cordifolia (Thunb.) Miers,” International Journal of Pharmacognosy and Phytochemical Research, vol. 8, no. 12, pp. 2020–2024, 2016. View at: Google Scholar
  11. H. E. Gottlieb, V. Kotlyar, and A. Nudelman, “NMR chemical shifts of common laboratory solvents as trace impurities,” The Journal of Organic Chemistry, vol. 62, no. 21, pp. 7512–7515, 1997. View at: Publisher Site | Google Scholar
  12. R. K. Harris, E. D. Becker, S. M. Cabral de Menezes, P. Granger, and R. E. Hoffman, “Further conventions for NMR shielding and chemical shifts (IUPAC Recommendations 2008),” Pure and Applied Chemistry, vol. 80, no. 1, pp. 59–84, 2008. View at: Publisher Site | Google Scholar
  13. U. Sharma, M. Bala, N. Kumar, B. Singh, R. K. Munshi, and S. Bhalerao, “Immunomodulatory active compounds from Tinospora cordifolia,” Journal of Ethnopharmacology, vol. 141, no. 3, pp. 918–926, 2012. View at: Publisher Site | Google Scholar
  14. M. Padma, B. Govindh, and B. Venkateswara, “Synthesis & characterization of fluorescent silver nanoparticles stabilized by Tinospora Cordifolia leaf extract a green procedure,” Journal of Engineering Research and Applications, vol. 4, no. 9, pp. 100–107, 2014. View at: Google Scholar
  15. T. Abbasi, J. Anuradha, and S. Abbasi, “Utilization of the terrestrial weed Guduchi (Tinospora cordifolia) in clean-green synthesis of gold nanoparticles,” Nanoscience & Technology, vol. 1, no. 3, pp. 1–7, 2014. View at: Publisher Site | Google Scholar
  16. N. Uddin, N. Akter, M. Sagar, and M. Habibur, “New stigmasterol and long chain alcohol from Tinospora cordifolia,” International Journal of Multidisciplinary Research and Development, vol. 2, no. 8, pp. 143–145, 2015. View at: Google Scholar
  17. H. Espinosa and Y. E. García, Tecnologías de nano/microencapsulación, Jalisco: CIATEJ, Zapopan, Mexico, 2017.
  18. S. Sultana, M. Ali, and M. Jameel, “Phytochemical investigation and isolation of new compounds from the stems of Tinospora cordifolia Miers,” Trends in Phytochemical Research (TPR), vol. 1, no. 2, pp. 83–92, 2017. View at: Google Scholar
  19. A. Sinha, H. Sharma, B. Singh, and A. Patnaik, “Phyto-chemical studies of methanol extracts of tinospora cordifolia stem by GC-MS,” World Journal of Pharmaceutical Research, vol. 6, no. 4, pp. 1319–1326, 2017. View at: Publisher Site | Google Scholar
  20. H. Fulcrand, C. Mané, S. Preys et al., “Direct mass spectrometry approaches to characterize polyphenol composition of complex samples,” Phytochemistry, vol. 69, no. 18, pp. 3131–3138, 2008. View at: Publisher Site | Google Scholar
  21. S. Ghosal and R. A. Vishwakarma, “Tinocordiside, a new rearranged cadinane sesquiterpene glycoside from Tinospora cordifolia,” Journal of Natural Products, vol. 60, no. 8, pp. 839–841, 1997. View at: Publisher Site | Google Scholar
  22. National Center for Biotechnology Information, PubChem Database, 9 Agosto, National Center for Biotechnology Information, Bethesda, MA, USA, 2009.
  23. K. Antul, P. Amandeep, S. Gurwinder, and C. Anuj, “Review on pharmacological profile of medicinal vine: Tinospora cordifolia,” Current Journal of Applied Science and Technology, vol. 35, no. 5, pp. 1–11, 2019. View at: Publisher Site | Google Scholar
  24. D. Singh and P. K. Chaudhuri, “Chemistry and pharmacology of Tinospora cordifolia,” Natural Product Communications, vol. 12, no. 2, pp. 299–308, 2016. View at: Google Scholar
  25. J. Chakraborty, M. S. Hafez Kabir, H. Banik et al., “In silico pass prediction, molecular docking and ADME/T property analysis of isolated compounds form Tinospora cordifolia for new thrombolytic drug discovery,” World Journal of Pharmaceutical Research, vol. 5, no. 7, pp. 1751–1760, 2016. View at: Google Scholar
  26. M. Balaa, P. Kumar Verma, S. Awasthi, N. Kumar, B. Lal, and B. Singh, “Chemical prospection of important ayurvedic plant Tinospora cordifolia by UPLC-DAD-ESI-QTOF-MS/MS and NMR,” Natural Product Communications, vol. 10, no. 1, pp. 43–48, 2015. View at: Publisher Site | Google Scholar
  27. M. A. M. Nawwar, S. A. M. Hussein, and I. Merfort, “NMR spectral analysis of polyphenols from punica granatum,” Phytochemistry, vol. 36, no. 3, pp. 793–798, 1994. View at: Publisher Site | Google Scholar
  28. W. Li, K. Weu, H. Fu, and K. Koike, “Structure and absolute configuration of clerodane diterpene glycosides and a rearranged cadinane sesquiterpene glycoside from the stems of Tinospora sinensis,” Journal of Natural Products, vol. 70, no. 12, pp. 1971–1976, 2007. View at: Google Scholar
  29. M. Girish and K. Priyadarshini, “Influence of Tinospora cordifolia on wound healing in albino rats,” International Journal of Pharma & Bio Sciences, vol. 3, no. 2, pp. 379–384, 2012. View at: Google Scholar

Copyright © 2020 Jeimmy González-Masís et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.